Top Searches
May 23, 2013
| PharmaWeek > UCB Plans 2000 Job Cuts



UCB Plans 2000 Job Cuts


Aug. 28—Belgian drug maker UCB has announced plans to cut 2000 jobs worldwide in an effort to speed the company’s transition to a specialty drug company. The patents on two of UCB’s largest drugs are expiring, and the company is hoping the layoffs will enable them to direct $444 million into CNS and immunology research. Bloomberg 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1
White Papers & Special Reports

Perceptive Informatics
Part One: Taming Technology Chaos
A Vision of eClinical’s Future
Sponsored by Perceptive Informatics
Complimentary Download


Accunet
Building a Scalable Big Data Infrastructure for Dynamic Workflows
Sponsored by Accunet
Complimentary Download


Sapio Sciences logo
Laboratory Management for Clinical and Research NGS Labs
Sponsored by Sapio Sciences, LLC
Complimentary Download
More White Papers & Special Reports
Life Science Webcasts & Podcasts

Waters
Analog to Digital (A/D) Converters.  What are they and what is their role in data integrity?
Sponsored by Waters
Analog to Digital (A/D) converters are commonplace in many analytical labs.  Join this session to learn how these devices work and the important role they can play in data quality and integrity.

Listen Now 

More Podcasts

Job Openings


Sponsored Links
RELATED
RESOURCES & PRODUCTS
Feasibility and Planning
Designing & Implementing a Clinical Enrollment Plan DVD
Designing & Implementing a Clinical Enrollment Plan DVD
Tools for Trainers: Clinical Research Job-Aids and Checklists


RELATED STORIES

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com. 

Cambridge Healthtech Institute

Footer Image
  • 250 First Avenue, Suite 300
  • Needham MA 02494
  • phone: 781-972-5400
  • fax: 781-972-5425
  • chi@healthtech.com